Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C

British Journal of Cancer

Volumn 98, Issue 3, 2008, Pages 580-586

  Tanaka, H ^a   Fujita, N ^a   Sugimoto, R ^a   Urawa, N ^a   Horiike, S ^a   Kobayashi, Y ^a   Iwasa, M ^a   Ma, N ^a   Kawanishi, S ^b   Watanabe, S ^c   Kaito, M ^a   Takei, Y ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c MIE UNIVERSITY   (Japan)

Author keywords

8 hydroxydeoxyguanosine; Free radicals; Hepatitis C virus; Immunohistochemistry; Iron; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE;

ADULT; ANALYTIC METHOD; ARTICLE; BIOCHEMISTRY; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; FEMALE; FIBROSIS; FOLLOW UP; HEPATITIS C; HISTOLOGY; HUMAN; IRON STORAGE; LIVER BIOPSY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; UNIVARIATE ANALYSIS;

CARCINOMA, HEPATOCELLULAR; DEOXYGUANOSINE; DNA DAMAGE; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 38949216684     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604204     Document Type: Article

References (32)

1. Cathcart R, Schwiers E, Saul RL, Ames BN (1984) Thymine glycol and thymidine glycol in human and rat urine: a possible assay for oxidative DNA damage. Proc Natl Acad Sci USA 81: 5633-5637
2. Crawford D, Cerutti P (1985) Expression of oxidant stress-related genes in tumor promotion of mouse epidermal cells JB6. In Oxidative Stress and Diseases Nygaard O, Simic M, Cerutti P (eds) pp 183-190. New York: Plenum Press
3. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ (1994) Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19: 1513-1520
4. Deugnier YM, Loreal O, Turlin B, Guyader D, Jouanolle H, Moirand R, Jacquelinet C, Brissot P (1992) Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 102: 2050-2059
5. Donato F, Tagger A, Chiesa R, Ribero ML, Tomasoni V, Fasola M, Gelatti U, Portera G, Boffetta P, Nardi G (1997) Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study. Hepatology 26: 579-584
6. El-Serag HB (2002) Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36(Suppl 1): S74-S83
7. El-Serag HB, Richardson PA, Everhart JE (2001) The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol 96: 2462-2467
8. Fujita N, Horiike S, Sugimoto R, Tanaka H, Iwasa M, Kobayashi Y, Hasegawa K, Ma N, Kawanishi S, Adachi Y, Kaito M (2007) Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients. Free Radic Biol Med 42: 353-562
9. Gebo KA, Chander G, Jenckes MW, Ghanem KG, Herlong HF, Torbenson MS, El-Kamary SS, Bass EB (2002) Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review. Hepatology 36(Suppl 1): S84-S92
10. Greten TF, Papendorf F, Bleck JS, Kirchhoff T, Wohlberedt T, Kubicka S, Klempnauer J, Galanski M, Manns MP (2005) Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer 92: 1862-1868
11. Hollstein MC, Brooks P, Linn S, Ames BN (1984) Hydroxymethyluracil DNA glycosylase in mammalian cells. Proc Natl Acad Sci USA 81: 4003-4007
12. Iwasa M, Iwata K, Kaito M, Ikoma J, Yamamoto M, Takeo M, Kuroda M, Fujita N, Kobayashi Y, Adachi Y (2004) Efficacy of long-term dietary restriction of total calories, fat, iron, and protein in patients with chronic hepatitis C. Nutrition 20: 368-371
13. Kasai H (1997) Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 387: 147-163
14. Kuchino Y, Mori F, Kasai H, Inoue H, Iwai S, Miura K, Ohtsuka E, Nishimura S (1987) Misreading of DNA templates containing 8- hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature 327: 77-79
15. Mahmood S, Kawanaka M, Kamei A, Izumi A, Nakata K, Niiyama G, Ikeda H, Hanano S, Suehiro M, Togawa K, Yamada G (2004) Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C. Antioxid Redox Signal 6: 19-24
16. Maki A, Kono H, Gupta M, Asakawa M, Suzuki T, Matsuda M, Fujii H, Rusyn I (2007) Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma. Ann Surg Oncol 14: 1182-1190
17. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K (1998) The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4: 1065-1067
18. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, Seki S, Kobayashi K, Otani S (1995) Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 346: 1051-1055
19. Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki H, Tsuji T, Yano M, Kuo G, Choo QL, Houghton M, Oda T (1991) A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 67: 429-433
20. Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, Yanagi K, Abiru S, Nakagawa Y, Shigeno M, Miyazoe S, Ichikawa T, Ishikawa H, Nakao K, Eguchi K (2003) Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 97: 3036-3043
21. Piperno A, Vergani A, Malosio I, Parma L, Fossati L, Ricci A, Bovo G, Boari G, Mancia G (1998) Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations. Hepatology 28: 1105- 109
22. Poli G, Parola M (1997) Oxidative damage and fibrogenesis. Free Radic Biol Med 22: 287-305
23. Ray RB, Lagging LM, Meyer K, Ray R (1996) Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 70: 4438-4443
24. Sakamuro D, Furukawa T, Takegami T (1995) Hepatitis C nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 69: 3893-3896
25. Seeff LB (2002) Natural history of chronic hepatitis C. Hepatology 36(Suppl 1): S35-S46
26. Shibutani S, Takeshita M, Grollman AP (1991) Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxoG. Nature 349: 431-434
27. Shigenaga M, Gimeno CJ, Ames BN (1989) Urinary 8-hydroxy-2′- deoxyguanosine as a biomarker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA 86: 9697-9701
28. Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, Kasai H (1994) Increased formation of oxidative DNA damage, 8- hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res 54: 3171-3172
29. Silvia IS, Perez RM, Oliveira PV, Cantagalo MI, Dantas E, Sisti C, Figueiredo-Mendes C, Lanzoni VP, Silva AE, Ferraz MG (2005) Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study. J Gastroentrol Hepatol 20: 243-248
30. Sumida Y, Nakashima T, Yoh T, Nakajima Y, Ishikawa H, Mitsuyoshi H, Sakamoto Y, Okanoue T, Kashima K, Nakamura H, Yodoi J (2000) Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J Hepatol 33: 616-622
31. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44-84
32. Yano M, Hayashi H, Yoshioka K, Kohgo Y, Saito H, Niitsu Y, Kato J, Iino S, Yotsuyamagi H, Kobayashi Y, Kawamura K, Kakumu S, Kaito M, Ikoma J, Wakusawa S, Okanoue T, Sumida Y, Kimura F, Kajiwara E, Sata M, Ogata K (2004) Significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan. J Gastroenterol 39: 570-574